Literature DB >> 26762242

Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models.

David M Irvin1, Robert S McNeill2,3, Ryan E Bash3, C Ryan Miller1,2,3,4,5.   

Abstract

The influence of cellular origin on glioma pathogenesis remains elusive. We previously showed that mutations inactivating Rb and Pten and activating Kras transform astrocytes and induce tumorigenesis throughout the adult mouse brain. However, it remained unclear whether astrocyte subpopulations were susceptible to these mutations. We therefore used genetic lineage tracing and fate mapping in adult conditional, inducible genetically engineered mice to monitor transformation of glial fibrillary acidic protein (GFAP) and glutamate aspartate transporter (GLAST) astrocytes and immunofluorescence to monitor cellular composition of the tumor microenvironment over time. Because considerable regional heterogeneity exists among astrocytes, we also examined the influence of brain region on tumor growth. GFAP astrocyte transformation induced uniformly rapid, regionally independent tumor growth, but transformation of GLAST astrocytes induced slowly growing tumors with significant regional bias. Transformed GLAST astrocytes had reduced proliferative response in culture and in vivo and malignant progression was delayed in these tumors. Recruited glial cells, including proliferating astrocytes, oligodendrocyte progenitors and microglia, were the majority of GLAST, but not GFAP astrocyte-derived tumors and their abundance dynamically changed over time. These results suggest that intrinsic astrocyte heterogeneity, and perhaps regional brain microenvironment, significantly contributes to glioma pathogenesis.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  astrocytes; genetically engineered mice; glioma; heterogeneity; microenvironment

Mesh:

Substances:

Year:  2016        PMID: 26762242      PMCID: PMC5322824          DOI: 10.1111/bpa.12348

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  71 in total

1.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  Changing numbers of neuronal and non-neuronal cells underlie postnatal brain growth in the rat.

Authors:  Fabiana Bandeira; Roberto Lent; Suzana Herculano-Houzel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

3.  Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.

Authors:  Lionel M L Chow; Raelene Endersby; Xiaoyan Zhu; Sherri Rankin; Chunxu Qu; Junyuan Zhang; Alberto Broniscer; David W Ellison; Suzanne J Baker
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

Review 4.  Cancer stem cells: at the headwaters of tumor development.

Authors:  Ryan J Ward; Peter B Dirks
Journal:  Annu Rev Pathol       Date:  2007       Impact factor: 23.472

5.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

6.  GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma.

Authors:  Ty W Abel; Cara Clark; Brian Bierie; Anna Chytil; Mary Aakre; Agnieszka Gorska; Harold L Moses
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

7.  Modeling Adult Gliomas Using RCAS/t-va Technology.

Authors:  Dolores Hambardzumyan; Nduka M Amankulor; Karim Y Helmy; Oren J Becher; Eric C Holland
Journal:  Transl Oncol       Date:  2009-05       Impact factor: 4.243

8.  Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrier.

Authors:  Yujie Huang; Caitlin Hoffman; Prajwal Rajappa; Joon-Hyung Kim; Wenhuo Hu; Jason Huse; Zhongshu Tang; Xuri Li; Babette Weksler; Jacqueline Bromberg; David C Lyden; Jeffrey P Greenfield
Journal:  Cancer Res       Date:  2013-12-26       Impact factor: 12.701

9.  Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.

Authors:  Ralf S Schmid; Jeremy M Simon; Mark Vitucci; Robert S McNeill; Ryan E Bash; Andrea M Werneke; Lauren Huey; Kristen K White; Matthew G Ewend; Jing Wu; C Ryan Miller
Journal:  Neuro Oncol       Date:  2016-01-28       Impact factor: 12.300

10.  Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression.

Authors:  Elena I Fomchenko; Joseph D Dougherty; Karim Y Helmy; Amanda M Katz; Alexander Pietras; Cameron Brennan; Jason T Huse; Ana Milosevic; Eric C Holland
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

View more
  16 in total

1.  Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target?

Authors:  Varun Subramaniam Venkatesh; Emil Lou
Journal:  Cancer Rep (Hoboken)       Date:  2019-05-08

2.  Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.

Authors:  Onyinyechukwu Okolie; Juli R Bago; Ralf S Schmid; David M Irvin; Ryan E Bash; C Ryan Miller; Shawn D Hingtgen
Journal:  Neuro Oncol       Date:  2016-06-13       Impact factor: 12.300

3.  Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.

Authors:  Ralf S Schmid; Jeremy M Simon; Mark Vitucci; Robert S McNeill; Ryan E Bash; Andrea M Werneke; Lauren Huey; Kristen K White; Matthew G Ewend; Jing Wu; C Ryan Miller
Journal:  Neuro Oncol       Date:  2016-01-28       Impact factor: 12.300

4.  Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma.

Authors:  Mark Vitucci; David M Irvin; Robert S McNeill; Ralf S Schmid; Jeremy M Simon; Harshil D Dhruv; Marni B Siegel; Andrea M Werneke; Ryan E Bash; Seungchan Kim; Michael E Berens; C Ryan Miller
Journal:  Neuro Oncol       Date:  2017-09-01       Impact factor: 12.300

5.  Tumor Microenvironment in Treatment of Glioma.

Authors:  Guijie Li; Zhigang Qin; Zhuo Chen; Lijuan Xie; Ren Wang; Hang Zhao
Journal:  Open Med (Wars)       Date:  2017-08-12

6.  In situ characterization of stem cells-like biomarkers in meningiomas.

Authors:  Hanin Alamir; Mona Alomari; Abdulla Ahmed A Salwati; Mohamad Saka; Mohammed Bangash; Saleh Baeesa; Fahad Alghamdi; Angel Carracedo; Hans-Juergen Schulten; Adeel Chaudhary; Adel Abuzenadah; Deema Hussein
Journal:  Cancer Cell Int       Date:  2018-05-25       Impact factor: 5.722

Review 7.  Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment.

Authors:  Belén Delgado-Martín; Miguel Ángel Medina
Journal:  Adv Sci (Weinh)       Date:  2020-03-12       Impact factor: 16.806

Review 8.  Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors.

Authors:  Diana Matias; Joana Balça-Silva; Grazielle C da Graça; Caroline M Wanjiru; Lucy W Macharia; Carla Pires Nascimento; Natalia R Roque; Juliana M Coelho-Aguiar; Cláudia M Pereira; Marcos F Dos Santos; Luciana S Pessoa; Flavia R S Lima; Alberto Schanaider; Valéria P Ferrer; Vivaldo Moura-Neto
Journal:  Front Cell Neurosci       Date:  2018-08-03       Impact factor: 5.505

Review 9.  Towards an advanced cell-based in vitro glioma model system.

Authors:  Valeriia Mikhailova; Valeriia Gulaia; Vladlena Tiasto; Stanislav Rybtsov; Margarita Yatsunskaya; Alexander Kagansky
Journal:  AIMS Genet       Date:  2018-03-19

10.  Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination.

Authors:  Hayato Une; Ryo Yamasaki; Satoshi Nagata; Hiroo Yamaguchi; Yuko Nakamuta; Ulfa Camelia Indiasari; Yiwen Cui; Koji Shinoda; Katsuhisa Masaki; Magdalena Götz; Jun-Ichi Kira
Journal:  J Neuroinflammation       Date:  2021-06-05       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.